FDANonrulemakingFDA-2021-D-0432

Who commented on this docket

Microbiological Quality Considerations in Non-Sterile Drug Manufacturing; Draft Guidance for Industry; Availability

2 organizations filed 2 public comments on Microbiological Quality Considerations in Non-Sterile Drug Manufacturing; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1672d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 1672d ago

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.